Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mar Drugs
2012 Jul 01;107:1605-1618. doi: 10.3390/md10071605.
Show Gene links
Show Anatomy links
Functional expression in Escherichia coli of the disulfide-rich sea anemone peptide APETx2, a potent blocker of acid-sensing ion channel 3.
Anangi R
,
Rash LD
,
Mobli M
,
King GF
.
???displayArticle.abstract???
Acid-sensing ion channels (ASICs) are proton-gated sodium channels present in the central and peripheral nervous system of chordates. ASIC3 is highly expressed in sensory neurons and plays an important role in inflammatory and ischemic pain. Thus, specific inhibitors of ASIC3 have the potential to be developed as novel analgesics. APETx2, isolated from the sea anemone Anthopleura elegantissima, is the most potent and selective inhibitor of ASIC3-containing channels. However, the mechanism of action of APETx2 and the molecular basis for its interaction with ASIC3 is not known. In order to assist in characterizing the ASIC3-APETx2 interaction, we developed an efficient and cost-effective Escherichia coli periplasmic expression system for the production of APETx2. NMR studies on uniformly (13)C/(15)N-labelled APETx2 produced in E. coli showed that the recombinant peptide adopts the native conformation. Recombinant APETx2 is equipotent with synthetic APETx2 at inhibiting ASIC3 channels expressed in Xenopus oocytes. Using this system we mutated Phe15 to Ala, which caused a profound loss of APETx2's activity on ASIC3. These findings suggest that this expression system can be used to produce mutant versions of APETx2 in order to facilitate structure-activity relationship studies.
Figure 1. (A) Schematic of construct encoding a His6-MBP: APETx2 fusion protein for production of rAPETx2 in E. coli. (B) SDS-PAGE gel showing expression and purification of rAPETx2. Lane 1: molecular mass standards (the size of selected standards is shown on left of gel); Lanes 2 and 3: E. coli cells before and after induction with IPTG; Lanes 4 and 5: insoluble and soluble fractions resulting from rupture of E. coli cells; Lanes 6 and 7: purified MBP fusion protein before and after cleavage with TEV protease. (C) RP-HPLC chromatogram showing the final purification of folded rAPETx2.
Figure 2. (A) RP-HPLC chromatogram showing co-elution of synthetic and recombinant APETx2. (B) MALDI-TOF mass spectrum showing m/z of pure rAPETx2. (C) MALDI-TOF mass spectrum showing m/z of pure rAPETx2-F15A.
Figure 3. Overlaid 2D 1H-15N HSQC spectrum of uniformly 15N-labelled wild-type rAPETx2 (blue) and a F15A mutant (red). Residues whose chemical shifts are most affected by the mutation of Phe15 to Ala are highlighted with green circles while the peak corresponding to F15 in the wild-type toxin is shown in a red box. The horizontal line connects the two peaks from the sidechain amide group of Asn8, and âW14 scâ indicates the peak from the sidechain indole NH group of Trp14.
Figure 4. (A) Representative current traces comparing the concentration-dependent inhibition of rat ASIC3 (expressed in Xenopus oocytes) by synthetic (s) and recombinant (r) APETx2. (B) Concentration-effect curves for sAPETx2 and an rAPETx2âF15A mutant.
Figure 5. Three-dimensional solution structure of APETx2 (PDB accession code 1WXN) showing the relative positions of the N- and C-termini, and the predicted interaction surface including the confirmed pharmacophore residues R17 [30] and F15 (this study).
Anangi,
Expression in Pichia pastoris and characterization of APETx2, a specific inhibitor of acid sensing ion channel 3.
2010, Pubmed
Anangi,
Expression in Pichia pastoris and characterization of APETx2, a specific inhibitor of acid sensing ion channel 3.
2010,
Pubmed
Benson,
Acid-evoked currents in cardiac sensory neurons: A possible mediator of myocardial ischemic sensation.
1999,
Pubmed
Blanchard,
Inhibition of voltage-gated Na(+) currents in sensory neurones by the sea anemone toxin APETx2.
2012,
Pubmed
,
Xenbase
Cabrita,
A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production.
2006,
Pubmed
Catterall,
International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.
2005,
Pubmed
Chagot,
Solution structure of APETx2, a specific peptide inhibitor of ASIC3 proton-gated channels.
2005,
Pubmed
Chen,
A role for ASIC3 in the modulation of high-intensity pain stimuli.
2002,
Pubmed
Deval,
ASIC3, a sensor of acidic and primary inflammatory pain.
2008,
Pubmed
Deval,
Acid-sensing ion channels (ASICs): pharmacology and implication in pain.
2010,
Pubmed
Deval,
Acid-sensing ion channels in postoperative pain.
2011,
Pubmed
Diochot,
A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons.
2004,
Pubmed
,
Xenbase
Escoubas,
Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels.
2003,
Pubmed
Hattori,
ASIC2a and ASIC3 heteromultimerize to form pH-sensitive channels in mouse cardiac dorsal root ganglia neurons.
2009,
Pubmed
Hermanstyne,
Mechanotransducers in rat pulpal afferents.
2008,
Pubmed
Ikeuchi,
Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice.
2008,
Pubmed
Jensen,
Chemical synthesis and folding of APETx2, a potent and selective inhibitor of acid sensing ion channel 3.
2009,
Pubmed
,
Xenbase
Karczewski,
Reversal of acid-induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2.
2010,
Pubmed
King,
Venoms as a platform for human drugs: translating toxins into therapeutics.
2011,
Pubmed
Kwan,
Macromolecular NMR spectroscopy for the non-spectroscopist.
2011,
Pubmed
Lingueglia,
Acid-sensing ion channels in sensory perception.
2007,
Pubmed
Maggio,
Scanning mutagenesis of a Janus-faced atracotoxin reveals a bipartite surface patch that is essential for neurotoxic function.
2002,
Pubmed
Meng,
Functional expression of spider neurotoxic peptide huwentoxin-I in E. coli.
2011,
Pubmed
Nagae,
Osteoclasts play a part in pain due to the inflammation adjacent to bone.
2006,
Pubmed
Oliveira,
Development of a rational nomenclature for naming peptide and protein toxins from sea anemones.
2012,
Pubmed
Price,
The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice.
2001,
Pubmed
Prinz,
The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm.
1997,
Pubmed
Saez,
A dynamic pharmacophore drives the interaction between Psalmotoxin-1 and the putative drug target acid-sensing ion channel 1a.
2011,
Pubmed
Sluka,
Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1.
2003,
Pubmed
Sluka,
Acid-sensing ion channels: A new target for pain and CNS diseases.
2009,
Pubmed
Sutherland,
Acid-sensing ion channel 3 matches the acid-gated current in cardiac ischemia-sensing neurons.
2001,
Pubmed
Tedford,
Functional significance of the beta hairpin in the insecticidal neurotoxin omega-atracotoxin-Hv1a.
2001,
Pubmed
Vetter,
Venomics: a new paradigm for natural products-based drug discovery.
2011,
Pubmed
Voilley,
Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors.
2001,
Pubmed
Walder,
Selective targeting of ASIC3 using artificial miRNAs inhibits primary and secondary hyperalgesia after muscle inflammation.
2011,
Pubmed
Wemmie,
Acid-sensing ion channels: advances, questions and therapeutic opportunities.
2006,
Pubmed
Wu,
Targeting ASIC3 for pain, anxiety, and insulin resistance.
2012,
Pubmed
Xiong,
Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases.
2008,
Pubmed
Yiangou,
Increased acid-sensing ion channel ASIC-3 in inflamed human intestine.
2001,
Pubmed
Yu,
A nonproton ligand sensor in the acid-sensing ion channel.
2010,
Pubmed
Yuan,
Acid-sensing ion channels 3: a potential therapeutic target for pain treatment in arthritis.
2010,
Pubmed